224 related articles for article (PubMed ID: 18337012)
1. Efficacy of different treatment regimens of marbofloxacin in canine visceral leishmaniosis: a pilot study.
Rougier S; Vouldoukis I; Fournel S; Pérès S; Woehrlé F
Vet Parasitol; 2008 May; 153(3-4):244-54. PubMed ID: 18337012
[TBL] [Abstract][Full Text] [Related]
2. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
3. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
Pasa S; Toz SO; Voyvoda H; Ozbel Y
Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
[TBL] [Abstract][Full Text] [Related]
4. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.
Manna L; Vitale F; Reale S; Caracappa S; Pavone LM; Morte RD; Cringoli G; Staiano N; Gravino AE
Vet Parasitol; 2004 Nov; 125(3-4):251-62. PubMed ID: 15482882
[TBL] [Abstract][Full Text] [Related]
6. PCR follow-up examination after treatment of canine leishmaniosis (CaL).
Steuber S; Moritz A; Schirrmann I; Greiner M
Tokai J Exp Clin Med; 1998 Dec; 23(6):285-92. PubMed ID: 10622624
[TBL] [Abstract][Full Text] [Related]
7. One-year clinical and parasitological follow-up of dogs treated with marbofloxacin for canine leishmaniosis.
Rougier S; Hasseine L; Delaunay P; Michel G; Marty P
Vet Parasitol; 2012 May; 186(3-4):245-53. PubMed ID: 22130335
[TBL] [Abstract][Full Text] [Related]
8. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
9. Use of domperidone in the treatment of canine visceral leishmaniasis: a clinical trial.
Gómez-Ochoa P; Castillo JA; Gascón M; Zarate JJ; Alvarez F; Couto CG
Vet J; 2009 Feb; 179(2):259-63. PubMed ID: 18023375
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of renal and hepatic functions in dogs naturally infected by visceral leishmaniasis submitted to treatment with meglumine antimoniate.
Ikeda-Garcia FA; Lopes RS; Ciarlini PC; Marques FJ; Lima VM; Perri SH; Feitosa MM
Res Vet Sci; 2007 Aug; 83(1):105-8. PubMed ID: 17150234
[TBL] [Abstract][Full Text] [Related]
11. Polyarthritis associated with visceral leishmaniasis in a juvenile dog.
Santos M; Marcos R; Assunção M; Matos AJ
Vet Parasitol; 2006 Nov; 141(3-4):340-4. PubMed ID: 16824686
[TBL] [Abstract][Full Text] [Related]
12. The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.
Cortese L; Pelagalli A; Piantedosi D; Mastellone V; Di Loria A; Lombardi P; Ciaramella P; Avallone L
Vet J; 2008 Sep; 177(3):405-10. PubMed ID: 17629526
[TBL] [Abstract][Full Text] [Related]
13. Nodular lesions of the tongue in canine leishmaniosis.
Parpaglia ML; Vercelli A; Cocco R; Zobba R; Manunta ML
J Vet Med A Physiol Pathol Clin Med; 2007 Oct; 54(8):414-7. PubMed ID: 17877582
[TBL] [Abstract][Full Text] [Related]
14. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate.
Ikeda-Garcia FA; Lopes RS; Marques FJ; de Lima VM; Morinishi CK; Bonello FL; Zanette MF; Perri SH; Feitosa MM
Vet Parasitol; 2007 Feb; 143(3-4):254-9. PubMed ID: 16996214
[TBL] [Abstract][Full Text] [Related]
15. Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
Medkour H; Bitam I; Laidoudi Y; Lafri I; Lounas A; Hamidat HK; Mekroud A; Varloud M; Davoust B; Mediannikov O
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008947. PubMed ID: 33338041
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial.
Corpas-López V; Merino-Espinosa G; Acedo-Sánchez C; Díaz-Sáez V; Navarro-Moll MC; Morillas-Márquez F; Martín-Sánchez J
Vet Res Commun; 2018 Jun; 42(2):121-130. PubMed ID: 29453596
[TBL] [Abstract][Full Text] [Related]
17. Treatment of canine pyoderma with ibafloxacin and marbofloxacin--fluoroquinolones with different pharmacokinetic profiles.
Horspool LJ; van Laar P; van den Bos R; Mawhinney I
J Vet Pharmacol Ther; 2004 Jun; 27(3):147-53. PubMed ID: 15189300
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil.
Andrade HM; Toledo VP; Pinheiro MB; Guimarães TM; Oliveira NC; Castro JA; Silva RN; Amorim AC; Brandão RM; Yoko M; Silva AS; Dumont K; Ribeiro ML; Bartchewsky W; Monte SJ
Vet Parasitol; 2011 Sep; 181(2-4):83-90. PubMed ID: 21641721
[TBL] [Abstract][Full Text] [Related]
19. Treatment of canine leishmaniosis with aminosidine at an optimized dosage regimen: a pilot open clinical trial.
Athanasiou LV; Saridomichelakis MN; Kontos VI; Spanakos G; Rallis TS
Vet Parasitol; 2013 Feb; 192(1-3):91-7. PubMed ID: 23140991
[TBL] [Abstract][Full Text] [Related]
20. Periodic administration of allopurinol is not effective for the prevention of canine leishmaniosis (Leishmania infantum) in the endemic areas.
Saridomichelakis MN; Mylonakis ME; Leontides LS; Billinis C; Koutinas AF; Galatos AD; Gouletsou P; Diakou A; Kontos VI
Vet Parasitol; 2005 Jun; 130(3-4):199-205. PubMed ID: 15905034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
